Log in

Oxyntomodulin from distal gut

Role in regulation of gastric and pancreatic functions

  • Original Articles
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

We studied the effects of intravenous infusion of synthetic oxyntomodulin (proglucagon 33–69), a potential hormone from the ileal mucosa, on fasting and postprandial gastric acid secretion, gastric emptying, gastroduodenal motility, and pancreatic secretion of trypsin and lipase measured simultaneously in six normal volunteers using multilumen tubes for infusion of markers, manometry, and aspiration of gastric and duodenal contents. The infusion resulted in plasma concentrations of 203±21 pmollliter (mean±sem) of oxyntomodulin, regarded as high but not unphysiological concentrations of the peptide. Oxyntomodulin almost abolished basal acid secretion and inhibited postprandial acid secretion by 35±10%. Gastric emptying decreased significantly; the time for 50% to leave the stomach increased from 17.3±2.2 min to 34.7±8.0 min. The postprandial gastroduodenal motility was massively inhibited by oxyntomodulin. Postprandial trypsin and lipase output was significantly inhibited by 56±12% and 42±11%, respectively, during oxyntomodulin infusion. However, pancreatic enzyme output was linearly related to gastric emptying and oxyntomodulin did not influence this relationship, suggesting that oxyntomodulins effect was due to its effect on gastric emptying. Oxyntomodulin seems to play an important role in the small intestinal inhibitory control of gastropancreatic functions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Germany)

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bataille D, Tatemoto K, Gespach C, Jörnvall H, Rosselin G, Mutt V: Isolation of glucagon-37 (bioactive enteroglucagon/oxyntomodulin) from porcine jejuno-ileum. Characterization of the peptide. FEBS Lett 46:79–87, 1982

    Google Scholar 

  2. Holst JJ: Evidence that enteroglucagon (II) is identical with the C-terminal sequence (residues 33–69) of glicentin. Biochem J 87:372–378, 1982

    Google Scholar 

  3. Sutherland EW, DeDuve C: Origin and distribution of the hyperglycemic-glycogenolytic factor of the pancreas. J Biol Chem 175:663–679, 1948

    Google Scholar 

  4. Bataille D, Coudray AM, Carlqvist M, Rosselin G, Mutt V: Isolation of glucagon 37 (bioactive enteroglucagon/oxyntomodulin from porcine jejuno-ileum. Isolation of the peptide. FEBS Lett 46:73–78, 1982

    Google Scholar 

  5. Baldissera FGA, Holst JJ: Glucagon-related peptides in the human gastrointestinal mucosa. Diabetologia 26:223–228, 1984

    PubMed  Google Scholar 

  6. Munck A, Kervran A, Marie JC, Bataille D, Rosselin G: Glucagon 37 (oxyntomodulin) and glucagon 29 (pancreatic glucagon) in human bowel: Analysis by HPLC and radioreceptor assay. Peptides 5:553–561, 1984

    PubMed  Google Scholar 

  7. Thim L, Moody AJ, Valverde I: Structure determination of glicentin (33-69) isolated from a single human intestine. Dig Dis Sci 29(suppl):A-88, 1984

    Google Scholar 

  8. Holst JJ: Molecular heterogeneity of glucagon in normal subjects and in patients with glucagon producing tumors. Diabetologia 24:359–365, 1983

    PubMed  Google Scholar 

  9. Holst JJ, Holst Pedersen J, Baldissera FGA, Stadil F: Circulating glucagon after total pancreatectomy in man. Diabetologia 25:396–399, 1983

    PubMed  Google Scholar 

  10. Kervran A, Blache P, Bataille D: Distribution of oxyntomodulin and glucagon in the gastrointestinal tract and the plasma of the rat. Endocrinology 121:807–813, 1987

    Google Scholar 

  11. Baldissera FGA, Holst JJ, Knuhtsen S, Hilsted L, Nielsen OV: Oxyntomodulin (glicentin 33-69): pharmacokinetics; binding to liver cell membranes, effects on isolated perfused pig pancreas, and secretion from isolated perfused lower small intestine of pigs. Regul Pept 21:151–166, 1988

    PubMed  Google Scholar 

  12. Mojsov S, Heinrich G, Wilson IB, Ravazzola M, Orci L, Habener JF: Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing. J Biol Chem 261:11880–11889, 1986

    PubMed  Google Scholar 

  13. Holst JJ, Olsen J, Lund T: Are the enteroglucagons encoded by the glucagon gene? Diabetologia 30:532A, 1987

    Google Scholar 

  14. Holst JJ: Enteroglucagon.In Advances in Metabolic Disorders. V. Mutt (ed). New York, Academic Press, 1988, pp 392–419

    Google Scholar 

  15. Holst JJ: Interactions of hepatocyte membrane receptors with pancreatic and gut glucagon.In Glucagon: Its Role in Physiology and Clinical Medicine. PP Foa, JS Baja, NL Foa (eds). New York, Springer Verlag, 1977, pp 2087–2303

    Google Scholar 

  16. Jarrousse C, Bataille D, Jeanrenaud B: A pure enteroglucagon oxyntomodulin (glucagon-37), stimulates insulin release in perfused rat pancreas. Endocrinology 115:102–105, 1984

    PubMed  Google Scholar 

  17. Bataille D, Gespach C, Coudray AM, Rosselin G: Enteroglucagon: A specific effect on gastric glands isolated from the rat fundus. Evidence for an oxyntomodulin action. Biosci Rep 1:151–155, 1981

    PubMed  Google Scholar 

  18. Dubrasquet M, Bataille D, Gespach C: Oxyntomodulin (glucagon-37 or bioactive enteroglucagon): A potent inhibitor of pentagastrin stimulated acid secretion in rats. Biosci Rep 2:391–395, 1982

    PubMed  Google Scholar 

  19. Bataille D, Gespach C, Tatemoto K, Marie JC, Coudray AM, Rosselin G, Mutt V: Bioactive enteroglucagon (oxyntomodulin): Present knowledge on its chemical structure and its biological activities. Peptides 2:41–44, 1981

    PubMed  Google Scholar 

  20. Jarrousse C, Niel H, Audousset-Puech M-P, Martinez J, Bataille D: Oxyntomodulin and its C-terminal octapeptide inhibit liquid meal-stimulated acid secretion. Peptides 7:253–256, 1986

    Google Scholar 

  21. Schjoldager B, Baldissera FGA, Mortensen PE, Christiansen J, Holst JJ: Oxyntomodulin, a potential hormone from the distal gut. Pharmacokinetics and effects on gastric acid secretion in man. Eur J Clin Invest 18:499–503, 1988

    PubMed  Google Scholar 

  22. Biedzinski TM, Bataille D, Devaux MA, Sarles H: The effect of oxyntomodulin (glucagon-37) and glucagon on exocrine pancreatic secretion in the conscious rat. Peptides 8:967–972, 1987

    PubMed  Google Scholar 

  23. Lawaetz O, Ohlsen HP, Andreasen R: Evaluation of gastric emptying by a single isotope technique. Scand J Gastroenterol 16:737–748, 1981

    PubMed  Google Scholar 

  24. Holst JJ, Christiansen J, Kuhl C: The enteroglucagon response to intrajejunal infusion of glucose, triglycerides, and sodium chloride, and its relation to jejunal inhibition of gastric acid secretion in man. Scand J Gastroenterol 11:297–304, 1976

    PubMed  Google Scholar 

  25. Holst JJ, Schwartz TW, Lovgren NA, Pedersen O, Beck-Nielsen H: Diurnal profile of pancreatic polypeptide, pancreatic glucagon, gut glucagon and insulin in human morbid obesity. Int J Obes 7:529–538, 1983

    PubMed  Google Scholar 

  26. Polonsky KS, Jaspan JB, Rubenstein AH: The metabolic clearance rate of glucagon.In Glucagon. Handbook of Experimental Pharmacology. PJ Lefebvre (ed). New York, Springer Verlag, 1983, pp 353–359

    Google Scholar 

  27. Go VLW, Hofmann AF, Summerskill WHJ: Simultaneous measurements of total pancreatic, biliary and gastric outputs in man using a perfusion technique. Gastroenterology 58:321–328, 1970

    PubMed  Google Scholar 

  28. Dimagno EP: Alterations and consequences of interdigestive and poststimulatory human exocrine pancreatic secretion in health and disease. Scand J Gastroenterol 12(suppl 87):69, 1983

    Google Scholar 

  29. Worning H, Mullertz S: pH and pancreatic enzymes in the human duodenum during digestion of a standard meal. Scand J Gastroenterol 1:268–283, 1966

    PubMed  Google Scholar 

  30. Holst JJ, Creutzfeldt M, Holm G, Jensen E, Poulsen D, Sparsø Birgitte, Sparsø B, Schmidt A: Persistent glucagonemia after pancreatectomy in pigs. Diabete Metab 4:75–79, 1978

    PubMed  Google Scholar 

  31. Hilsted L, Holst JJ: On the accuracy of radioimmunological determination of somatostatin in plasma. Regul Pept 4:13–31, 1982

    PubMed  Google Scholar 

  32. Widdonson GM, Penton JR: Determination of serum and plasma glucose on “autoanalyzer II” by use of hexokinase reaction. Clin Chem 18:299–300, 1972

    PubMed  Google Scholar 

  33. Malagelada J-R, Longstreth GF, Summerskill WHJ, Go VLW: Measurement of gastric functions during digestion of ordinary solid meals in man. Gastroenterology 70:203–210, 1976

    PubMed  Google Scholar 

  34. Christiansen J, Holst JJ, Kalaja E: Inhibition of gastric acid in man by exogenous and exogenous pancreatic glucagon. Gastroenterology 70:688–692, 1976

    PubMed  Google Scholar 

  35. Thomas PA, Akvari OE, Kelly KA: Hormonal control of gastrointestinal motility. World J Surg 3:543–552, 1979

    Google Scholar 

  36. Miller RE, Chernish SM: The response of gastrointestinal tract motility to glucagon.In Glucagon in Gastroenterology and Hepatology. J Picazo (ed). Boston, MTP Press, 1982, pp 37–54

    Google Scholar 

  37. Dyck WP, Texter EC, Lasater JM, Hightower NC: Interfluence of glucagon on pancreatic exocrine secretion in man. Gastroenterology 58:532–539, 1970

    PubMed  Google Scholar 

  38. Samols E:In Glucagon. Handbook of Experimental Pharmacology. PJ Lefebvre (ed). New York, Springer Verlag, 1983, pp 448–518

    Google Scholar 

  39. Rees WDW, Go VLW, Malagelada J-R: Simultaneous measurement of antroduodenal motility, gastric emptying, and duodenogastric reflux in man. Gut 20:963–970, 1979

    PubMed  Google Scholar 

  40. Schjoldager B, Lawaetz O, Christiansen J: Effect of pancreatic glucagon and its 1–21 fragment on gastric emptying in man. Scand J Gastroenterol 23:726–730, 1988

    PubMed  Google Scholar 

  41. Miller LJ, Malagelada J-R, Taylor WF, Go VLW: Intestinal control of postprandial gastric function: The role of components of jejunoileal chyme in regulating gastric secretion and gastric emptying. Gastroenterology 80:763–769, 1981

    PubMed  Google Scholar 

  42. Walsh JH: Gastrointestinal Hormones.In Physiology of the Gastrointestinal Tract. LR Johnson (ed). New York, Raven Press, 1987, pp 246–257

    Google Scholar 

  43. Solomon TE: Control of exocrine pancreatic secretion.In Physiology of the Gastrointestinal Tract. LR Johnson (ed). New York, Raven Press, 1987, pp 1173–1207

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This study was supported by grants from the Danish Medical Research Council and Lægeforeningens Forskningsfond.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schjoldager, B., Mortensen, P.E., Myhre, J. et al. Oxyntomodulin from distal gut. Digest Dis Sci 34, 1411–1419 (1989). https://doi.org/10.1007/BF01538078

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01538078

Key words

Navigation